FC
ARNA

FORA Capital’s Arena Pharmaceuticals Inc ARNA Stock Holding History

FORA Capital’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,744
Closed -$324K – 981
2021
Q2 		$324K Buy
+4,744
New +$309K 0.06% 347
2021
Q1 		– Sell
-813
Closed -$62K – 1227
2020
Q4 		$62K Buy
+813
New +$60.9K 0.01% 749
2020
Q3 		– Sell
-6,398
Closed -$403K – 1096
2020
Q2 		$403K Buy
+6,398
New +$352K 0.14% 196
2020
Q1 		– Sell
-1,769
Closed -$80K – 1438
2019
Q4 		$80K Buy
+1,769
New +$83.6K 0.01% 793

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

FORA Capital's ARNA Position: Q3 2021 in Review

FORA Capital sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2021, closing a stake of 4,744 shares — an estimated $324K sold.

FORA Capital first reported a position in ARNA in Q4 2019 and held it in 4 quarters. The position peaked at $403K in Q2 2020. 235 funds tracked by Wall St. Rank hold ARNA as of Q3 2021.

  • FORA Capital reported no remaining Arena Pharmaceuticals Inc position as of Q3 2021 after selling out during the quarter.
  • FORA Capital sold 4,744 Arena Pharmaceuticals Inc shares in Q3 2021, an estimated $324K.
  • FORA Capital first reported a position in Arena Pharmaceuticals Inc in Q4 2019 and held it in 4 quarters.
  • FORA Capital's Arena Pharmaceuticals Inc position peaked at $403K in Q2 2020.
  • 235 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2021.

Based on FORA Capital's 13F filing for Q3 2021, filed 15 Nov 2021.